RELATE - Efficacy and Feasibility of a Cognitive Behavioural Module for Distressing Auditory Verb… (NCT04578314) | Clinical Trial Compass
CompletedNot Applicable
RELATE - Efficacy and Feasibility of a Cognitive Behavioural Module for Distressing Auditory Verbal Hallucinations
Germany85 participantsStarted 2020-10-01
Plain-language summary
Auditory hallucinations (AH) are associated with distress and reduced functioning. Psychological interventions show some promising effects on psychopathology but have been less successful in reducing AH related distress, which patients report to be a priority. Research suggests that distress is associated with the hearer relating to AH in a passive and subordinate manner. A novel approach thus teaches assertive responses to AH through the use of experiential role-plays. A single centre pilot study in the United Kingdom evidenced a large effect of this approach on AH distress but independent multicentre studies are required to ascertain effectiveness across different settings. The planned feasibility trial aims to estimate the expected effect for a subsequent fully powered prospective, randomized, controlled, parallel-group, two-armed, multicentre, open trial set up to demonstrate that adding a Relating Module (RM) to Treatment as Usual (TAU) is superior to TAU alone. Feasibility questions relate to patient recruitment, therapist training and therapy monitoring in different types of psychological and psychiatric outpatient facilities.
Who can participate
Age range16 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. have a diagnosis of a schizophrenia spectrum disorder (ICD-10, F2, confirmed by SCID-5)
✓. patients will be reporting distressing AH for at least six months (to be beyond the startle and adjustment phase ) and score ≥ 3 on either item 8 or item 9 of the PSYRATS-AH;
✓. be ≥ 16 years of age
✓. be judged able to understand the full implications of their decision by the responsible psychiatrist or clinical psychologist.
Exclusion criteria
✕. have AH with a clear organic cause (e.g. brain disease or injury):
✕. have exclusively hypnagogic or hypnopompic AH,
✕. have a primary diagnosis of acute substance dependence (F1x.2)
✕. have completed a course of CBT for psychotic symptoms during the past year within which distressing AH have been targeted
✕. be currently participating, or be confirmed to participate in another interventional study in which they are receiving an intervention which utilizes psychological therapy ;
What they're measuring
1
The Psychotic Symptom Rating Scales-AH-Distress factor score (PSYRATS-AH)